ITRE reaches agreement on FP7

The European Parliament's Industry, Research and Energy Committee (ITRE) has adopted, in a second reading, a set of comprise amendments on the Seventh Framework Programme (FP7), which were agreed upon in informal meetings with the Council.

The 39 new amendments deal with issues such as the structure of the European Research Council (ERC) and the proposed Risk Sharing Finance Facility (RSFF).

MEPs agreed on an amendment on renewable and end use energy, which foresees a 'major part' of the budget from FP7's energy theme going to the field, instead of two thirds as proposed by the Parliament in its first reading. According to ITRE, special attention will be devoted to the coordination of issues linked to rational and efficient use of energy in FP7 and in other EU policies.

A compromise was also reached regarding the administrative costs of the ERC, which should now not exceed 5% - MEPs had originally asked for a limit of 3%. On the issue of the Parliament's involvement in the interim evaluation of the ERC, it was agreed to opt for co-decision procedure in case changes in the structure of ERC become necessary.

ITRE also endorsed amendments on the rules of participation for companies, research centres and universities, as well as the RSFF, which is designed to encourage bank lending to research projects. Initially, the Council had planned to allocate €1 billion from the FP7 budget to finance RSFF. However, under the amendment, a lower contribution of €500 million is foreseen until 2010, with the possibility of releasing the additional €500 million after a review.

On the European Institute of Technology (EIT), the committee stressed that no money from FP7 should be used to finance the proposed structure. Only administrative costs directly associated with research projects may be covered.

The amended text will be put to the vote at a Parliament plenary session, due to be held on 29 November, before it is put to the Council on 5 December.

If all goes to plan, the first calls for proposals for FP7 projects could be published by December 2006, with closing dates in March 2007. Following an evaluation period, the first FP7 projects could start as early as the end of 2007 or early 2008

For further information on FP7, please visit:
http://cordis.europa.eu/fp7/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...